en
svPress releases
Press release 2025-01-20
Xspray Pharma reports strong interim data for product candidate XS003 – confirms plan to apply for market approval in H1 2025
Regulatory press release 2024-12-30
New number of shares and votes in Xspray Pharma after rights issue
Regulatory press release 2024-12-04
Xspray publishes the final outcome of the rights issue
Regulatory press release 2024-12-02
Strong interest in Xspray Pharma AB’s rights issue – preliminary outcome is published
Regulatory press release 2024-11-14
Xspray publishes prospectus relating to the rights issue
Regulatory press release 2024-11-06
Interim Report Third Quarter 2024
Regulatory press release 2024-11-06
Xspray resolves on a rights issue of approximately SEK 135 million and raises a loan of SEK 100 million
Regulatory press release 2024-10-21
Xspray Pharma’s Nomination Committee for the Annual General Meeting 2025
Press release 2024-09-19
Xspray Pharma Announces Positive FDA Meeting and Plans for Dasynoc NDA Resubmission
Regulatory press release 2024-08-07